Acute chest syndrome: Sickle cell disease

European Journal of Haematology

Volumn 87, Issue 3, 2011, Pages 191-207

  Paul, Rabindra N ^a   Castro, Oswaldo L ^b   Aggarwal, Anita ^a   Oneal, Patricia A ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY   (United States)

Author keywords

Acute chest syndrome; Anemia; Asthma; Lung diseases; Pulmonary hypertension; Sickle cell disease

Indexed keywords

ARGININE; BETA LACTAM; BRAIN NATRIURETIC PEPTIDE; BRONCHODILATING AGENT; CEPHALOSPORIN; DEXAMETHASONE; ENDOTHELIN 1; EPTIFIBATIDE; HEMOGLOBIN A; HEMOGLOBIN F; HEMOGLOBIN S; HLA DR ANTIGEN; HYDROXYUREA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LOW MOLECULAR WEIGHT HEPARIN; MACROLIDE; MEPACRINE; MORPHINE; NALBUPHINE; NITRIC OXIDE; PEPTIDOLEUKOTRIENE; POLOXAMER; PREDNISONE; PROTEIN HLA DRB1; QUINOLONE; SECRETORY PHOSPHOLIPASE A2; TINZAPARIN; TROPONIN I; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CHEST SYNDROME; ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; ASTHMA; BLOOD GAS ANALYSIS; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRONCHOSPASM; CIGARETTE SMOKING; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DOSE COMPARISON; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FAT EMBOLISM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH FREQUENCY VENTILATION; HUMAN; HYPOVENTILATION; HYPOXIA; INCIDENCE; INFECTION RISK; LEUKOCYTE COUNT; LUNG EMBOLISM; MORTALITY; OXYGENATION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; PULMONARY VASCULAR OBSTRUCTIVE DISEASE; PULSE OXIMETRY; RESPIRATORY FAILURE; RETICULOCYTE COUNT; REVIEW; RISK FACTOR; SEASONAL VARIATION; SEIZURE; SICKLE CELL ANEMIA; THORAX PAIN; THROMBOCYTE COUNT; VENOUS THROMBOEMBOLISM;

ACUTE CHEST SYNDROME; ANEMIA, SICKLE CELL; ARTERIAL OCCLUSIVE DISEASES; ASTHMA; HUMANS; OXYGEN;

EID: 84860389611     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01647.x     Document Type: Review

References (167)

1. Barrett-Connor E. Acute pulmonary disease and sickle cell anemia. Am Rev Respir Dis 1971;104:155-65.
2. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med 1979;139:67-9.
3. Vichinsky EP, Neumayr LD, Earles AN, et al., National Acute Chest Syndrome Study Group. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000;342:1855-65.
4. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994;84:643-9.
5. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: Clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997;89:1787.
6. Quinn CT, Shull EP, Ahmad N, Lee NJ, Rogers ZR, Buchanan GR. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. Blood 2007;109:40.
7. Graham LM Jr. The effect of sickle cell disease on the lung. Clin Pulmonary Med 2004;11:369.
8. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine 1988;67:66-76.
9. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 1991;44:459-63.
10. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
11. Pagnier J, Mears JG, Belkhodja OD, Schaefer-Rego KE, Beldjord C, Nagel RL. Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci USA 1984;81:1771-3.
12. Kulozik AE, Wainscoat JS, Serjeant GR, Kar BC, Al-Awamy B, Essan GJ. Geographical survey of b-globin gene haplotypes: evidence for an independent Asian origin of sickle cell mutation. Am J Hum Genet 1986;39:239-44.
13. Lapoumroulie C, Dunda O, Ducrocq R, Trabucht G, Mony-Lobe M, Bodo JM. A novel sickle gene of yet another origin in Africa: the Cameroon type. Hum Genet 1992;89:333-7.
14. Alabdulaali MK. Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes. Ann Thorac Med 2007;2:158-62.
15. Mahdi N, Al-Subaie AM, Al-Ola K, Al-Irhayim AQ, Ali ME, Al-Irhayim Z, Almawi WY. HLA DRB1*130101-DQB1*060101 haplotype is associated with acute chest syndrome in sickle cell anemia patients. Tissue Antigens 2009;73:245-9.
16. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60:206-10.
17. Nordness ME, Lynn J, Zacharisen MC, Scott PJ, Kelly KJ. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin. Mol Allergy 2005;3:2.
18. Young RC Jr, Rachal RE, Hackney RL Jr, Uy CG, Scott RB. Smoking is a factor in causing acute chest syndrome in sickle cell anemia. J Natl Med Assoc 1992;84:267-71.
19. Cohen RT, DeBaun MR, Blinder MA, Strunk RC, Field JJ. Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease. Blood 2010;115:3852-4.
20. Wales PW, Carver E, Crawford MW, Kim PC. Acute chest syndrome after abdominal surgery in children with sickle cell disease: Is a laparoscopic approach better? J Pediatr Surg 2001;36:718-21.
21. Kokoska ER, West KW, Carney DE, Engum SE, Heiny ME, Rescorla FJ. Risk factors for acute chest syndrome in children with sickle cell disease undergoing abdominal surgery. J Pediatr Surg 2004;39:848-50.
22. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995;333:206-13.
23. Morris CR, Kuypers FA, Larkin S, Vichinsky EP, Styles LA. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000;22:515-20.
24. Sullivan KJ, Kissoon N, Gauger C. Nitric oxide metabolism and the acute chest syndrome of sickle cell anemia. Pediatr Crit Care Med 2008;9:159-68.
25. Chaar V, Tarer V, Etienne-Julan M, Diara JP, Elion J, Romana M. ET-1 and ecNOS gene polymorphisms and susceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia. Haematologica 2006;91:1277-8.
26. Sharan K, Surrey S, Ballas S, Borowski M, Devoto M, Wang KF, Sandler E, Keller M. Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Haematol 2004;124:240-3.
27. Rackoff WR, Kunkel N, Silber JH, Asakura T, Ohene-Frempong K. Pulse oximetry and factors associated with hemoglobin oxygen desaturation in children with sickle cell disease. Blood 1993;81:3422-7.
28. Hargrave DR, Wade A, Evans JP, Hewes DK, Kirkham FJ. Nocturnal oxygen saturation and painful sickle cell crises in children. Blood 2003;101:846-8.
29. Buchanan ID, Woodward M, Reed GW. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatr Blood Cancer 2005;45:716-24.
30. Lewing K, Britton K, Debaun M, Woods G. The impact of parenteral narcotic choice in the development of acute chest syndrome in sickle cell disease. J Pediatr Hematol Oncol 2011;33:255-60.
31. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin Pharmacol Ther 2004;75:140-6.
32. Jennings JE, Ramkumar T, Mao J, Boyd J, Castro M, Field JJ, Strunk RC, DeBaun MR. Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease. Am J Hematol 2008;83:640-3.
33. Field JJ, Krings J, White NL, Yan Y, Blinder MA, Strunk RC, Debaun MR. Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease. Am J Hematol 2009;84:158-60.
34. Telen MJ. Role of adhesion molecules and vascular endothelium in the pathogenesis of sickle cell disease. Hematology Am Soc Hematol Educ Program 2007; 2007:84.
35. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007; 2007:91.
36. Graham LM. Sickle cell disease: pulmonary management options. Pediatr Pulmonol Suppl 2004;26:191.
37. Aldrich TK, Dhuper SK, Patwa NS, Makolo E, Suzuka SM, Najeebi SA, Santhanakrishnan S, Nagel RL, Fabry ME. Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol 1996;80:531-9.
38. Barrett-Connor E. Acute pulmonary disease in sickle cell anemia. Am Rev Respir Dis 1971;104:159-65.
39. Steinberg B. Sickle cell anemia. Arch Pathol 1930;9:876-97.
40. Haupt HM, Moore W, Bauer TW, Hutchins GM. The lung in sickle cell disease. Chest 1982;81:332-7.
41. Bhalla M, Abboud MR, McLoud TC, Shepard JA, Munden MM, Jackson SM, Beaty JR, Laver JH. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology 1993;187:45-9.
42. Walker BK, Ballas SK, Burka ER. The diagnosis of pulmonary thromboembolism in sickle cell disease. Am J Hematol 1979;7:219-32.
43. Babiker MA, Obeid HA, Ashong EF. Acute reversible pulmonary ischemia: a cause of the acute chest syndrome in sickle cell disease. Clin Pediatr 1985;24:716-8.
44. Frenette P. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol 2002;9:101-6.
45. Setty BNY, Stuart MJ. Vascular cell adhesion molecule -1 is involved in mediating hypoxia induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 1996;88:2311-20.
46. Matsui NM, Borsig L, Rosen SD, Yaghmai M, Varki A, Embury SH. P-selectin mediates the adhesion of sickle erythrocytes to the endothelium. Blood 2001;98:1955-62.
47. Hebbel RP. Auto-oxidation and a membrane-associated 'Fenton reagent': A possible explanation for development of membrane lesions in sickle erythrocytes. Clin Haematol 1985;14:129-40.
48. Repka T, Hebbel RP. Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. Blood 1991;78:2753-8.
49. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004;11:129-51.
50. Browne P, Shalev O, Hebbel RP. The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med 1998;24:1040-8.
51. Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 1998;92:3924-35.
52. Shiu Y-T, Udden MM, McIntire LV. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells. Blood 2000;95:3232-41.
53. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-66.
54. Yuan XJ, Wang J, Juhaszova M, Gaine SP, Rubin LJ. Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 1998;351:726-7.
55. Hammerman SI, Kourembanas S, Conca TJ, Tucci M, Brauer M, Farber HW. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 1997;156:280-5.
56. Moncada S, Higgs A. Mechanisms of disease: the L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
57. Morris CR, Kuypers FA, Larkin S, Vichinsky EP, Styles LA. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000;22:515-20.
58. Morris CR, Kuypers FA, Larkin S, Sweeters N, Simon J, Vichinsky EP, Styles LA. Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol 2000;111:498-500.
59. Rees DC, Cervi P, Grimwade D, O'Driscoll A, Hamilton M, Parker NE, Porter JB. The metabolites of nitric oxide in sickle-cell disease. Br J Haematol 1995;91:834-7.
60. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-8.
61. Haynes J Jr, Taylor AE, Dixon D, Voelkel N. Microvascular hemodynamics in the sickle red blood cell perfused isolated rat lung. Am J Physiol 1993;264:H484-9.
62. Klings ES, Christman BW, McClung J, Stucchi AF, McMahon L, Brauer M, Farber HW. Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress. Am J Respir Crit Care Med 2001;7:1248-52.
63. Vichinsky E, Williams R, Das M, Earles AN, Lewis N, Adler A, McQuitty J. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-12.
64. Godeau B, Schaeffer A, Bachir D, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996;153:1691-6.
65. Case Records of the Massachusetts General Hospital (Case 34-1997). N Engl J Med 1997;337:1293-301.
66. Gladwin MT, Rodgers GP. Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia. Lancet 2000;355:1476-8.
67. 2 1.levels in acute chest syndrome of sickle cell disease. Blood 1996;87:2573-8.
68. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333:699-703.
69. Gelfand MJ, Daya SA, Rucknagel DL, Kalinyak KA, Paltiel HJ. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. J Nucl Med 1993;34:614-8.
70. Ballas SK, Park CH. Severe hypoxemia secondary to acute sternal infarction in sickle cell anemia. J Nucl Med 1991;32:1617-8.
71. Sprinkle RH, Cole T, Smith S, Buchanan GR. Acute chest syndrome in children with sickle cell disease. Am J Pediatr Hematol Oncol 1986;8:105-10.
72. Palmer J, Broderick KA, Naiman JL. Acute lung syndrome during painful sickle cell crisis: relation to site of pain and narcotic requirement [abstract]. Blood 1983;62:59a.
73. Barrett-Connor E. Pneumonia and pulmonary infarction in sickle cell anemia. JAMA 1973;224:997-1000.
74. Dean D, Neumayr L, Kelly DM, et al. Acute Chest Syndrome Study Group. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. J Pediatr Hematol Oncol 2003;25:46.
75. Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough? Ann Emerg Med 1999;34:64-9.
76. Martin L, Buonomo C. Acute chest syndrome of sickle cell disease: radiographic and clinical analysis of 70 cases. Pediatr Radiol 1997;27:637-41.
77. Van Agtmael MA, Cheng JD, Nossent HC. Acute chest syndrome in adult Afro-Caribbean patients with sickle cell disease. Arch Intern Med 1994;154:557-61.
78. Davies SC, Luce PJ, Win AA, Riordan JF. Acute chest syndrome in sickle-cell disease. Lancet 1984;1:36-8.
79. Charache S, Scott JC, Charache P. Acute chest syndrome in adults with sickle cell anemia: microbiology, treatment, and prevention. Arch Intern Med 1979;139:67-9.
80. Lisbona R, Derbekyan V, Novales-Diaz JA. Scintigraphic evidence of pulmonary vascular occlusion in sickle cell disease. J Nucl Med 1997;38:1151-3.
81. Poncz M, Kane E, Gill FM. Acute chest syndrome in sickle cell disease: etiology and clinical correlates. J Pediatr 1985;107:861-6.
82. Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998;92:3082-9.
83. Barker SJ, Tremper KK. Pulse oximetry: applications and limitations. Int Anesthesiol Clin 1987;25:155-75.
84. Kress JP, Pohlman AS, Hall JB. Determination of hemoglobin saturation in patients with acute sickle chest syndrome: a comparison of arterial blood gases and pulse oximetry. Chest 1999;115:1316-20.
85. Ortiz FO, Aldrich TK, Nagel RL, Benjamin LJ. Accuracy of pulse oximetry in sickle cell disease. Am J Respir Crit Care Med 1999;159:447-51.
86. 2 saturation. J Appl Physiol 1989;67:2135-40.
87. Kirkpatrick MB, Haynes J, Bass JB Jr. Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome. Am J Med 1991;90:206-10.
88. Maitre B, Habibi A, Roudot-Thoraval F, Bachir D, Belghiti DD, Galacteros F, Godeau B. Acute chest syndrome in adults with sickle cell disease: therapeutic approach, outcome, and results of BAL in a monocentric series of 107 episodes. Chest 2000;117:1386-92.
89. Moser C, Nussbaum E, Cooper DM. Plastic bronchitis and the role of bronchoscopy in the acute chest syndrome of sickle cell disease. Chest 2001;120:608-13.
90. Mekontso Dessap A, Leon R, Habibi A, et al. Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease. Am J Respir Crit Care Med 2008;177:646-53.
91. Baur M, Schmid T-O, Landauer B. Role of phospholipase A in multiorgan failure with special reference to ARDS and acute renal failure (ARF). Klin Wochenschr. 1989;67:196-202.
92. Vadas P. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med 1984;104:873-86.
93. Henderson WR Jr. Eicosanoids and lung inflammation. Am Rev Respir Dis 1987;135:11761185.
94. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-55.
95. Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 1998;92:2551-5.
96. 2 predicts impending acute chest syndrome in sickle cell disease. Blood 2000;96:3276-8.
97. Bargoma EM, Mitsuyoshi JK, Larkin SK, Styles LA, Kuypers FA, Test ST. Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome. Blood 2005;8:3384-5.
98. Weil JV, Castro O, Malik AB, Rodgers G, Bonds DR, Jacobs TP. NHLBI Workshop Summary. Pathogenesis of lung disease in sickle hemoglobinopathies. Am Rev Respir Dis 1993;148:249-56.
99. Minniti CP, Sable C, Campbell A, et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica 2009;94:340-7.
100. Colombatti R, Maschietto N, Varotto E, Grison A, Grazzina N, Meneghello L, Teso S, Carli M, Milanesi O, Sainati L. Pulmonary hypertension in sickle cell disease children under 10years of age. Br J Haematol 2010;150:601-9.
101. Henderson JN, Noetzel MJ, McKinstry RC, White DA, Armstrong M, DeBaun MR. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 2003;101:415-9.
102. Lee KH, McKie VC, Sekul EA, Adams RJ, Nichols FT. Unusual encephalopathy after acute chest syndrome in sickle cell disease: acute necrotizing encephalitis. J Pediatr Hematol Oncol 2002;24:585-8.
103. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-95.
104. Charache S. Sickle cells and sudden death. J Lab Clin Med 1994;124:473-4.
105. Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 2006;119:897.
106. Santoli F, Zerah F, Vasile N, Bachir D, Galacteros F, Atlan G. Pulmonary function in sickle cell disease with or without acute chest syndrome. Eur Respir J 1998;12:1124-9.
107. Sylvester KP, Patey RA, Milligan P, Rafferty GF, Broughton S, Rees D, Thein SL, Greenough A. Impact of acute chest syndrome on lung function of children with sickle cell disease. Pediatr 2006;149:17-22.
108. Ozbek OY, Malbora B, Sen N, Yazici AC, Ozyurek E, Ozbek N. Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease. Pediatr Pulmonol 2007;42:1187-92.
109. Leong MA, Dampier C, Varlotta L, Allen JL. Airway hyperreactivity in children with sickle cell disease J Pediatr 1997;131:278-83.
110. Boyd JH, Moinuddin A, Strunk RC, DeBaun MR. Asthma and acute chest in sickle-cell disease. Pediatr Pulmonol 2004;38:229-32.
111. Sen N, Kozanoglu I, Karatasli M, Ermis H, Boga C, Eyuboglu FO. Pulmonary function and airway hyperresponsiveness in adults with sickle cell disease. Lung 2009;187:195-200. Epub 2009 Mar 20.
112. Johnson CS, Verdegem TV. Pulmonary complications of sickle cell disease. Semin Resp Med 1988;9:287-93.
113. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease. Lung 2010;188:499-504.
114. Guglin M, Rivero A, Matar F, Garcia M. Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol 2011;34:113-6.
115. Audard V, Homs S, Habibi A, et al. Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension. Nephrol Dial Transplant 2010;25:2524-9.
116. Tedla FM, Friedman EA. Multiorgan failure during a sickle cell crisis in sickle/beta-thalassemia. Am J Kidney Dis 2003;42:E6-8.
117. Hassell KL, Eckman JR, Lane PA. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 1994;96:155-62.
118. Hiran S. Multiorgan dysfunction syndrome in sickle cell disease. J Assoc Physicians India 2005;53:19-22.
119. Chehal A, Taher A, Shamseddine A. Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura. Hemoglobin 2002;26:345-51.
120. Dreyer ZE. Chest infections and syndromes in sickle cell disease of childhood. Semin Respir Infect 1996;11:163-72.
121. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin Pharmacol Ther 2004;75:140-6.
122. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995;127:901-4.
123. Van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007;82:955-60.
124. Emre U, Miller ST, Gutierez M, Steiner P, Rao SP, Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995;127:901-4.
125. Turner JM, Kaplan JB, Cohen HW, Billett HH. Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults. Transfusion 2009;49:863-8.
126. Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2010;1:1-12.
127. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2007;2:1-14.
128. Gray GC, Mitchell BS, Tueller JE, Cross ER, Amundson DE. Pneumonia hospitalizations in the US Navy and Marine Corps: rates and risk factors for 6, 522 admissions, 1981-1991. Am J Epidemiol 1994;139:793-802.
129. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997;87:988.
130. Sullivan KJ, Goodwin SR, Evangelist J, Moore RD, Mehta P. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999;27:2563-8.
131. Head CA, Brugnara C, Martinez-Ruiz R, Kacmarek RM, Bridges KR, Kuter D, Bloch KD, Zapol WM. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest 1997;100:1193-8.
132. Al Hajeri A, Serjeant G, Fedorowicz Z. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2008;1:1-9.
133. Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 2003;289:1136-42.
134. Gladwin MT, Kato GJ, Weiner D, et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 2011;305:893-902.
135. Kumar R, Qureshi S, Mohanty P, Rao SP, Miller ST. A short course of prednisone in the management of acute chest syndrome of sickle cell disease. J Pediatr Hematol Oncol 2010;32:e91-4.
136. Strouse JJ, Takemoto CM, Keefer JR, Kato GJ, Casella JF. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood Cancer 2008;50:1006-12.
137. Sobota A, Graham DA, Heeney MM, Neufeld EJ. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am J Hematol 2010;85:24-8.
138. Wratney AT, Gentile MA, Hamel DS, Cheifetz IM. Successful treatment of acute chest syndrome with high-frequency oscillatory ventilation in pediatric patients. Respir Care 2004;49:263-9.
139. Enwonwu CO, Xu XX, Turner E. Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine. Am J Med Sci 1990;300:366-71.
140. Lopez BL, Kreshak AA, Morris CR, Davis-Moon L, Ballas SK, Ma XL. L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department. Br J Haematol 2003;120:532-4.
141. Xia Y, Dawson V, Dawson T, Snyder S, Zweier J. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitritemediated cellular injury. Proc Natl Acad Sci USA 1996;93:6770-4.
142. Morris CR, Morris SM Jr, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003;168:63-9.
143. Romero JR, Suzuka SM, Nagel RL, Fabry ME. Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity. Blood 2002;99:1103-8.
144. Styles L, Kuypers F, Kesler K, Reiss U, Lebeau P, Nagel R, Fabry M. Arginine therapy does not benefit children with sickle cell anemia - results of the CSCC clinical trial consortium multiinstitutional study [abstract]. Blood 2007;110:2252.
145. Matsui NM, Varki A, Embury SH. Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood 2002;100:3790-6.
146. Qari MH, Aljaouni SK, Alardawi MS, et al. Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. Thromb Haemost 2007;98:392-6.
147. Lee SP, Ataga KI, Zayed M, Manganello JM, Orringer EP, Phillips DR, Parise LV. Phase I study of eptifibatide in patients with sickle cell anaemia. Br J Haematol 2007;139:612-20.
148. Trant CA Jr, Casey JR, Hansell D, Cheifetz I, Meliones JN, Ungerleider RM, Browning I, Greeley WJ. Successful use of extracorporeal membrane oxygenation in the treatment of acute chest syndrome in a child with severe sickle cell anemia. ASAIO J 1996;42:236-9.
149. Pelidis MA, Kato GJ, Resar LM, Dover GJ, Nichols DG, Walker LK, Casella JF. Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation. J Pediatr Hematol Oncol 1997;19:459-61.
150. Tsukahara Y, Morisaki T, Horita Y, Torisu M, Tanaka M. Phospholipase A2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis. Ann Surg 1999;229:385-92.
151. Lee YM, Hybertson BM, Terada LS, Repine AJ, Cho HG, Repine JE. Mepacrine decreases lung leak in rats given interleukin-1 intratracheally. Am J Respir Crit Care Med 1997;155:1624-8.
152. Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM. Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin 2004;28:85-102.
153. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-9.
154. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
155. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP. Hydroxyurea and sickle cell anemia. Medicine (Baltimore) 1996;75:300-26.
156. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease-rates and risk factors. N Engl J Med 1991;325:11-6.
157. Ataga KI. Novel therapies in sickle cell disease. Hematology Am Soc Hematol Educ Program 2009;1:54-61.
158. Saunthararajah Y, Hillery CA, Lavelle D, Molokie R, Dorn L, Bressler L, Gavazova S, Chen YH, Hoffman R, DeSimone J. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood 2003;102:3865-70.
159. Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J. Clinical effectiveness of decitabine in severe sickle cell disease. Br J Haematol 2008;141:126-9.
160. Atweh GF, Sutton M, Nassif I, et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 1999;93:1790-7.
161. Hankins J, Jeng M, Harris S, Li CS, Liu T, Wang W. Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 2005;27:158-61.
162. Miller ST, Wright E, Abboud M, Berman B, Files B, Scher CD, Styles L, Adams RJ. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-9.
163. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999;340:1021-30.
164. Walters MC, Patience M, Leisenring W, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001;7:665-73.
165. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, Amylon M, Sullivan KM, Storb RF, Walters MC. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003;9:519-28.
166. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;6:2137-43.
167. Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009;361:2309-17.